DocuSign, Inc. (NASDAQ:DOCU – Get Free Report) CEO Allan C. Thygesen sold 7,725 shares of the stock in a transaction dated Thursday, August 1st. The shares were sold at an average price of $54.89, for a total value of $424,025.25. Following the completion of the sale, the chief executive officer now owns 109,918 shares of the company’s stock, valued at approximately $6,033,399.02. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.
DocuSign Stock Down 3.5 %
Shares of NASDAQ DOCU opened at $51.73 on Monday. The stock’s 50 day moving average price is $53.95 and its two-hundred day moving average price is $55.98. DocuSign, Inc. has a 52-week low of $38.11 and a 52-week high of $64.76. The stock has a market capitalization of $10.59 billion, a P/E ratio of 99.48, a PEG ratio of 8.34 and a beta of 0.94.
DocuSign (NASDAQ:DOCU – Get Free Report) last posted its quarterly earnings results on Thursday, June 6th. The company reported $0.29 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.20 by $0.09. DocuSign had a return on equity of 15.44% and a net margin of 3.81%. The business had revenue of $709.64 million for the quarter, compared to analyst estimates of $706.07 million. On average, analysts anticipate that DocuSign, Inc. will post 0.88 EPS for the current year.
Institutional Trading of DocuSign
Wall Street Analysts Forecast Growth
Several analysts have issued reports on DOCU shares. Bank of America lowered their price objective on shares of DocuSign from $72.00 to $60.00 and set a “neutral” rating for the company in a research report on Friday, June 7th. Morgan Stanley dropped their price target on shares of DocuSign from $65.00 to $62.00 and set an “equal weight” rating on the stock in a research note on Friday, June 7th. JMP Securities reissued a “market outperform” rating and issued a $84.00 price objective on shares of DocuSign in a research report on Wednesday, July 10th. Piper Sandler cut their price target on DocuSign from $65.00 to $60.00 and set a “neutral” rating on the stock in a research note on Friday, June 7th. Finally, UBS Group upgraded DocuSign from a “sell” rating to a “neutral” rating and raised their price objective for the company from $48.00 to $62.00 in a research note on Friday, April 12th. Two investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $59.36.
Read Our Latest Report on DocuSign
DocuSign Company Profile
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Read More
- Five stocks we like better than DocuSign
- The How And Why of Investing in Oil Stocks
- Market Crash? No Problem for DoorDash Stock’s Impressive Earnings
- Which Wall Street Analysts are the Most Accurate?
- Snap’s Stock Plummets on Q2 Revenue Guidance Shortfall
- Investing in Construction Stocks
- Hims & Hers Stock Falls on DexCom Fears: Analysts Predict Rally
Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.